Drug Shortage Report for TEVA-GLICLAZIDE
| Report ID | 88164 |
| Drug Identification Number | 02238103 |
| Brand name | TEVA-GLICLAZIDE |
| Common or Proper name | GLICLAZIDE |
| Company Name | TEVA CANADA LIMITED |
| Market Status | MARKETED |
| Active Ingredient(s) | GLICLAZIDE |
| Strength(s) | 80MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | 100 & 500 |
| ATC code | A10BB |
| ATC description | BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS |
| Reason for shortage | Shortage of an active ingredient. |
| Anticipated start date | |
| Actual start date | 2019-07-02 |
| Estimated end date | 2020-07-31 |
| Actual end date | 2020-07-22 |
| Shortage status | Resolved |
| Updated date | 2020-07-23 |
| Company comments | Delays getting API for next lots. Allocating to 100% of our market. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v1 | 2019-07-02 | English | Compare |
| v2 | 2019-07-02 | French | Compare |
| v3 | 2019-07-03 | English | Compare |
| v4 | 2019-08-09 | English | Compare |
| v5 | 2019-08-09 | French | Compare |
| v6 | 2019-08-22 | English | Compare |
| v7 | 2019-08-22 | French | Compare |
| v8 | 2019-08-29 | English | Compare |
| v9 | 2019-08-29 | French | Compare |
| v10 | 2019-09-19 | English | Compare |
| v11 | 2019-09-19 | French | Compare |
| v12 | 2019-10-17 | English | Compare |
| v13 | 2019-10-17 | French | Compare |
| v14 | 2019-10-24 | English | Compare |
| v15 | 2019-10-24 | French | Compare |
| v16 | 2019-10-31 | English | Compare |
| v17 | 2019-10-31 | French | Compare |
| v18 | 2019-12-05 | English | Compare |
| v19 | 2019-12-05 | French | Compare |
| v20 | 2020-01-09 | English | Compare |